HIGHLIGHTS
- who: Lucas Bu00f6ttcher from the am Main, Germany have published the article: A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development, in the Journal: (JOURNAL)
- what: The authors illustrate how such a refunding scheme can solve the antibiotics dilemma (AMR) Action Fund the authors discuss how the proposed incentivization scheme could be financed. To overcome the antibiotics dilemma and associated complications, the authors propose a refunding scheme to incentivize the development and appropriate use of antibiotics. The aim of the refunding scheme is to financially incentivize pharmaceutical companies to reorient their R and amp;D . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.